Working its way through a CRL on lead drug, Supernus taps $150M loan

As Rockville, MA-based Supernus works its way back to the FDA’s good graces with a lead Parkinson’s drug, it is tapping into a $150 million line of credit.

UBS Bank USA is providing the loan, which Supernus says can be drawn at any time at a fixed interest rate.